Cite
The association between changes in hepatic steatosis and hepatic fibrosis with cardiovascular outcomes and mortality in patients with New-Onset type 2 Diabetes: A nationwide cohort study.
MLA
Park, Jiyun, et al. “The Association between Changes in Hepatic Steatosis and Hepatic Fibrosis with Cardiovascular Outcomes and Mortality in Patients with New-Onset Type 2 Diabetes: A Nationwide Cohort Study.” Diabetes Research & Clinical Practice, vol. 194, Dec. 2022, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.diabres.2022.110191.
APA
Park, J., Kim, G., Kim, B.-S., Han, K.-D., Yoon Kwon, S., Hee Park, S., Lee, Y.-B., Jin, S.-M., & Hyeon Kim, J. (2022). The association between changes in hepatic steatosis and hepatic fibrosis with cardiovascular outcomes and mortality in patients with New-Onset type 2 Diabetes: A nationwide cohort study. Diabetes Research & Clinical Practice, 194, N.PAG. https://doi.org/10.1016/j.diabres.2022.110191
Chicago
Park, Jiyun, Gyuri Kim, Bong-Sung Kim, Kyung-Do Han, So Yoon Kwon, So Hee Park, You-Bin Lee, Sang-Man Jin, and Jae Hyeon Kim. 2022. “The Association between Changes in Hepatic Steatosis and Hepatic Fibrosis with Cardiovascular Outcomes and Mortality in Patients with New-Onset Type 2 Diabetes: A Nationwide Cohort Study.” Diabetes Research & Clinical Practice 194 (December): N.PAG. doi:10.1016/j.diabres.2022.110191.